Cardiovascular Systems (NASDAQ:CSII) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Thursday, January 4th.

A number of other equities analysts have also issued reports on CSII. William Blair reaffirmed a “market perform” rating on shares of Cardiovascular Systems in a research report on Thursday, December 21st. Needham & Company LLC lowered shares of Cardiovascular Systems from a “buy” rating to a “hold” rating and dropped their target price for the stock from $33.11 to $23.00 in a research report on Friday, December 15th. Raymond James Financial reiterated a “hold” rating on shares of Cardiovascular Systems in a research note on Monday, December 4th. Zacks Investment Research upgraded shares of Cardiovascular Systems from a “sell” rating to a “hold” rating in a research note on Monday, November 13th. Finally, Citigroup started coverage on shares of Cardiovascular Systems in a research note on Thursday, September 21st. They issued a “market perform” rating on the stock. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company’s stock. Cardiovascular Systems has a consensus rating of “Hold” and a consensus target price of $31.50.

Cardiovascular Systems (CSII) opened at $25.68 on Thursday. Cardiovascular Systems has a 52-week low of $23.00 and a 52-week high of $33.11. The company has a market cap of $880.34, a P/E ratio of 1,290.00 and a beta of 2.53. The company has a debt-to-equity ratio of 0.18, a current ratio of 4.30 and a quick ratio of 3.83.

Hedge funds have recently made changes to their positions in the company. BNP Paribas Arbitrage SA increased its stake in shares of Cardiovascular Systems by 160.7% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 5,135 shares of the medical device company’s stock valued at $166,000 after acquiring an additional 3,165 shares during the last quarter. BlueCrest Capital Management Ltd bought a new stake in shares of Cardiovascular Systems in the 2nd quarter valued at about $204,000. Legal & General Group Plc increased its stake in shares of Cardiovascular Systems by 2.9% in the 2nd quarter. Legal & General Group Plc now owns 7,763 shares of the medical device company’s stock valued at $249,000 after acquiring an additional 216 shares during the last quarter. Advisor Group Inc. increased its stake in shares of Cardiovascular Systems by 0.4% in the 2nd quarter. Advisor Group Inc. now owns 8,165 shares of the medical device company’s stock valued at $263,000 after acquiring an additional 35 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of Cardiovascular Systems by 34.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 8,239 shares of the medical device company’s stock valued at $265,000 after purchasing an additional 2,115 shares during the period. 75.35% of the stock is owned by institutional investors.

WARNING: “Cardiovascular Systems (NASDAQ:CSII) Lifted to “Sell” at BidaskClub” was first reported by Marea Informative and is owned by of Marea Informative. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at https://www.mareainformativa.com/2018/01/30/cardiovascular-systems-csii-upgraded-at-bidaskclub-updated-updated-updated.html.

Cardiovascular Systems Company Profile

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Analyst Recommendations for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.